Why Did SoundHound AI Stock Go Up?
SoundHound AI (NASDAQ:SOUN) has moved higher in recent days, breaking…
Sell
36
OSUR Quote, Financials, Valuation and Earnings
Last price:
$2.68
Seasonality move
:
13.64%
Day range:
$2.72 - $2.81
52-week range:
$2.08 - $4.22
Dividend yield:
0%
P/E ratio:
26.67x
P/S ratio:
1.61x
P/B ratio:
0.54x
Volume:
450.8K
Avg. volume:
647.7K
1-year change:
-30.08%
Market cap:
$195.1M
Revenue:
$185.8M
EPS (TTM):
-$0.81
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
OSUR
OraSure Technologies, Inc.
|
$26.4M | -$0.15 | -29.38% | -5.2% | $4.50 |
|
BSX
Boston Scientific Corp.
|
$5.3B | $0.78 | 11.57% | 76.14% | $124.41 |
|
CATX
Perspective Therapeutics, Inc.
|
$231.1K | -$0.35 | -57.02% | -40.33% | $12.3077 |
|
INFU
InfuSystem Holdings, Inc.
|
$36.7M | $0.05 | 8.36% | 39.86% | $14.20 |
|
VNRX
VolitionRX Ltd.
|
$714.1K | -$0.04 | 227.21% | -28.83% | $2.20 |
|
XTNT
Xtant Medical Holdings, Inc.
|
$30.8M | -- | -2.42% | -100% | $1.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
OSUR
OraSure Technologies, Inc.
|
$2.72 | $4.50 | $195.1M | 26.67x | $0.00 | 0% | 1.61x |
|
BSX
Boston Scientific Corp.
|
$91.29 | $124.41 | $135.3B | 48.83x | $0.00 | 0% | 7.04x |
|
CATX
Perspective Therapeutics, Inc.
|
$2.6700 | $12.3077 | $198.5M | -- | $0.00 | 0% | 181.04x |
|
INFU
InfuSystem Holdings, Inc.
|
$8.65 | $14.20 | $175.9M | 33.08x | $0.00 | 0% | 1.30x |
|
VNRX
VolitionRX Ltd.
|
$0.29 | $2.20 | $35.5M | -- | $0.00 | 0% | 19.79x |
|
XTNT
Xtant Medical Holdings, Inc.
|
$0.62 | $1.50 | $87.1M | 60.99x | $0.00 | 0% | 0.68x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
OSUR
OraSure Technologies, Inc.
|
3.59% | 0.867 | 5.8% | 5.99x |
|
BSX
Boston Scientific Corp.
|
33.99% | 0.384 | 8.31% | 0.81x |
|
CATX
Perspective Therapeutics, Inc.
|
1.35% | 3.042 | 1.3% | 8.47x |
|
INFU
InfuSystem Holdings, Inc.
|
30.8% | 4.042 | 11.73% | 1.35x |
|
VNRX
VolitionRX Ltd.
|
-48.16% | 2.723 | 15.4% | 0.04x |
|
XTNT
Xtant Medical Holdings, Inc.
|
39.2% | 3.120 | 35.76% | 1.08x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
OSUR
OraSure Technologies, Inc.
|
$10.4M | -$15.7M | -14.75% | -15.25% | -58.02% | -$11M |
|
BSX
Boston Scientific Corp.
|
$3.3B | $1B | 8.19% | 12.46% | 20.55% | $1.2B |
|
CATX
Perspective Therapeutics, Inc.
|
-$566K | -$27.9M | -37.13% | -37.63% | -13330.62% | -$18.3M |
|
INFU
InfuSystem Holdings, Inc.
|
$20.3M | $3.8M | 6.43% | 9.93% | 10.45% | $8.4M |
|
VNRX
VolitionRX Ltd.
|
$318.2K | -$5.1M | -- | -- | -813.17% | -$3.5M |
|
XTNT
Xtant Medical Holdings, Inc.
|
$22M | $2.5M | 2.15% | 3.78% | 7.64% | $4.2M |
OraSure Technologies, Inc. vs. Competitors
-
Which has Higher Returns OSUR or BSX?
Boston Scientific Corp. has a net margin of -50.63% compared to OraSure Technologies, Inc.'s net margin of 14.91%. OraSure Technologies, Inc.'s return on equity of -15.25% beat Boston Scientific Corp.'s return on equity of 12.46%.
Company Gross Margin Earnings Per Share Invested Capital OSUROraSure Technologies, Inc.38.29% -$0.19 $375.4M BSXBoston Scientific Corp.65.31% $0.50 $35.7B -
What do Analysts Say About OSUR or BSX?
OraSure Technologies, Inc. has a consensus price target of $4.50, signalling upside risk potential of 65.44%. On the other hand Boston Scientific Corp. has an analysts' consensus of $124.41 which suggests that it could grow by 36.28%. Given that OraSure Technologies, Inc. has higher upside potential than Boston Scientific Corp., analysts believe OraSure Technologies, Inc. is more attractive than Boston Scientific Corp..
Company Buy Ratings Hold Ratings Sell Ratings OSUROraSure Technologies, Inc.1 2 0 BSXBoston Scientific Corp.26 1 0 -
Is OSUR or BSX More Risky?
OraSure Technologies, Inc. has a beta of 0.771, which suggesting that the stock is 22.858% less volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.670, suggesting its less volatile than the S&P 500 by 33.029%.
-
Which is a Better Dividend Stock OSUR or BSX?
OraSure Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OraSure Technologies, Inc. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OSUR or BSX?
OraSure Technologies, Inc. quarterly revenues are $27.1M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.1B. OraSure Technologies, Inc.'s net income of -$13.7M is lower than Boston Scientific Corp.'s net income of $755M. Notably, OraSure Technologies, Inc.'s price-to-earnings ratio is 26.67x while Boston Scientific Corp.'s PE ratio is 48.83x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OraSure Technologies, Inc. is 1.61x versus 7.04x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OSUROraSure Technologies, Inc.1.61x 26.67x $27.1M -$13.7M BSXBoston Scientific Corp.7.04x 48.83x $5.1B $755M
-
Which has Higher Returns OSUR or CATX?
Perspective Therapeutics, Inc. has a net margin of -50.63% compared to OraSure Technologies, Inc.'s net margin of -12425.36%. OraSure Technologies, Inc.'s return on equity of -15.25% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.
Company Gross Margin Earnings Per Share Invested Capital OSUROraSure Technologies, Inc.38.29% -$0.19 $375.4M CATXPerspective Therapeutics, Inc.-270.81% -$0.35 $245.5M -
What do Analysts Say About OSUR or CATX?
OraSure Technologies, Inc. has a consensus price target of $4.50, signalling upside risk potential of 65.44%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 360.96%. Given that Perspective Therapeutics, Inc. has higher upside potential than OraSure Technologies, Inc., analysts believe Perspective Therapeutics, Inc. is more attractive than OraSure Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OSUROraSure Technologies, Inc.1 2 0 CATXPerspective Therapeutics, Inc.12 1 0 -
Is OSUR or CATX More Risky?
OraSure Technologies, Inc. has a beta of 0.771, which suggesting that the stock is 22.858% less volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.182, suggesting its more volatile than the S&P 500 by 18.151%.
-
Which is a Better Dividend Stock OSUR or CATX?
OraSure Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OraSure Technologies, Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OSUR or CATX?
OraSure Technologies, Inc. quarterly revenues are $27.1M, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. OraSure Technologies, Inc.'s net income of -$13.7M is higher than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, OraSure Technologies, Inc.'s price-to-earnings ratio is 26.67x while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OraSure Technologies, Inc. is 1.61x versus 181.04x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OSUROraSure Technologies, Inc.1.61x 26.67x $27.1M -$13.7M CATXPerspective Therapeutics, Inc.181.04x -- $209K -$26M
-
Which has Higher Returns OSUR or INFU?
InfuSystem Holdings, Inc. has a net margin of -50.63% compared to OraSure Technologies, Inc.'s net margin of 6.19%. OraSure Technologies, Inc.'s return on equity of -15.25% beat InfuSystem Holdings, Inc.'s return on equity of 9.93%.
Company Gross Margin Earnings Per Share Invested Capital OSUROraSure Technologies, Inc.38.29% -$0.19 $375.4M INFUInfuSystem Holdings, Inc.55.65% $0.11 $80.2M -
What do Analysts Say About OSUR or INFU?
OraSure Technologies, Inc. has a consensus price target of $4.50, signalling upside risk potential of 65.44%. On the other hand InfuSystem Holdings, Inc. has an analysts' consensus of $14.20 which suggests that it could grow by 64.16%. Given that OraSure Technologies, Inc. has higher upside potential than InfuSystem Holdings, Inc., analysts believe OraSure Technologies, Inc. is more attractive than InfuSystem Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OSUROraSure Technologies, Inc.1 2 0 INFUInfuSystem Holdings, Inc.5 0 0 -
Is OSUR or INFU More Risky?
OraSure Technologies, Inc. has a beta of 0.771, which suggesting that the stock is 22.858% less volatile than S&P 500. In comparison InfuSystem Holdings, Inc. has a beta of 1.680, suggesting its more volatile than the S&P 500 by 68.01%.
-
Which is a Better Dividend Stock OSUR or INFU?
OraSure Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InfuSystem Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OraSure Technologies, Inc. pays -- of its earnings as a dividend. InfuSystem Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OSUR or INFU?
OraSure Technologies, Inc. quarterly revenues are $27.1M, which are smaller than InfuSystem Holdings, Inc. quarterly revenues of $36.5M. OraSure Technologies, Inc.'s net income of -$13.7M is lower than InfuSystem Holdings, Inc.'s net income of $2.3M. Notably, OraSure Technologies, Inc.'s price-to-earnings ratio is 26.67x while InfuSystem Holdings, Inc.'s PE ratio is 33.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OraSure Technologies, Inc. is 1.61x versus 1.30x for InfuSystem Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OSUROraSure Technologies, Inc.1.61x 26.67x $27.1M -$13.7M INFUInfuSystem Holdings, Inc.1.30x 33.08x $36.5M $2.3M
-
Which has Higher Returns OSUR or VNRX?
VolitionRX Ltd. has a net margin of -50.63% compared to OraSure Technologies, Inc.'s net margin of -862.39%. OraSure Technologies, Inc.'s return on equity of -15.25% beat VolitionRX Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital OSUROraSure Technologies, Inc.38.29% -$0.19 $375.4M VNRXVolitionRX Ltd.50.73% -$0.05 -$24.7M -
What do Analysts Say About OSUR or VNRX?
OraSure Technologies, Inc. has a consensus price target of $4.50, signalling upside risk potential of 65.44%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.20 which suggests that it could grow by 661.77%. Given that VolitionRX Ltd. has higher upside potential than OraSure Technologies, Inc., analysts believe VolitionRX Ltd. is more attractive than OraSure Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OSUROraSure Technologies, Inc.1 2 0 VNRXVolitionRX Ltd.4 2 0 -
Is OSUR or VNRX More Risky?
OraSure Technologies, Inc. has a beta of 0.771, which suggesting that the stock is 22.858% less volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.234, suggesting its more volatile than the S&P 500 by 23.404%.
-
Which is a Better Dividend Stock OSUR or VNRX?
OraSure Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OraSure Technologies, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OSUR or VNRX?
OraSure Technologies, Inc. quarterly revenues are $27.1M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. OraSure Technologies, Inc.'s net income of -$13.7M is lower than VolitionRX Ltd.'s net income of -$5.4M. Notably, OraSure Technologies, Inc.'s price-to-earnings ratio is 26.67x while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OraSure Technologies, Inc. is 1.61x versus 19.79x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OSUROraSure Technologies, Inc.1.61x 26.67x $27.1M -$13.7M VNRXVolitionRX Ltd.19.79x -- $627.3K -$5.4M
-
Which has Higher Returns OSUR or XTNT?
Xtant Medical Holdings, Inc. has a net margin of -50.63% compared to OraSure Technologies, Inc.'s net margin of 3.93%. OraSure Technologies, Inc.'s return on equity of -15.25% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.
Company Gross Margin Earnings Per Share Invested Capital OSUROraSure Technologies, Inc.38.29% -$0.19 $375.4M XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M -
What do Analysts Say About OSUR or XTNT?
OraSure Technologies, Inc. has a consensus price target of $4.50, signalling upside risk potential of 65.44%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 141.12%. Given that Xtant Medical Holdings, Inc. has higher upside potential than OraSure Technologies, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than OraSure Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OSUROraSure Technologies, Inc.1 2 0 XTNTXtant Medical Holdings, Inc.2 0 0 -
Is OSUR or XTNT More Risky?
OraSure Technologies, Inc. has a beta of 0.771, which suggesting that the stock is 22.858% less volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.077, suggesting its less volatile than the S&P 500 by 107.701%.
-
Which is a Better Dividend Stock OSUR or XTNT?
OraSure Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OraSure Technologies, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OSUR or XTNT?
OraSure Technologies, Inc. quarterly revenues are $27.1M, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. OraSure Technologies, Inc.'s net income of -$13.7M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, OraSure Technologies, Inc.'s price-to-earnings ratio is 26.67x while Xtant Medical Holdings, Inc.'s PE ratio is 60.99x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OraSure Technologies, Inc. is 1.61x versus 0.68x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OSUROraSure Technologies, Inc.1.61x 26.67x $27.1M -$13.7M XTNTXtant Medical Holdings, Inc.0.68x 60.99x $33.3M $1.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Goldman Sachs Going to Go Up?
Shares of financial giant Goldman Sachs (NYSE:GS) have soared by…
How High Will MSTR Stock Go?
After several months of pressure, shares of Bitcoin treasury Strategy…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
69
INTC alert for Jan 23
Intel Corp. [INTC] is down 17.6% over the past day.
Buy
51
APGE alert for Jan 23
Apogee Therapeutics, Inc. [APGE] is down 10.71% over the past day.
Buy
70
BNR alert for Jan 23
Burning Rock Biotech Ltd. [BNR] is down 12.45% over the past day.
